Tuesday, August 21, 2018

Latest:

Revealing unique features of the ‘antennae’ on light-sensing neurons
Healthy Habits: Dr. Everton Edmondson enjoys tai chi and brisk walks
Know the signs of PTSD
Is there really a perfect way to study humans?
From the labs to commercialization: Companies merge to implement Baylor College of Medicine-developed therapies for cancer

Baylor College of Medicine Blog Network

Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
PolicyWise
- About PolicyWise
- Follow @BCMEthics on Twitter
Progress Notes
- About Progress Notes
- Connect With Us
GoWoman
bcm.edu

scours

From The Labs

From the Labs to Commercialization: the Estes lab and ImmuCell Success Story

February 6, 2018February 9, 2018 Ana Rodríguez 1 Comment Baylor Licensing Group, calf gastroenteritis, gastroenteritis, ImmuCell, Mary Estes lab, rotavirus, rotavirus vaccine, scours, virus-like particles

Research discoveries at Baylor College of Medicine can potentially reach the point where they evolve into practical applications that improve

From The Labs Image of the Month

From The Labs features the cytoplasmic distribution of p53-R175H mutant protein (green) in TYK-Nu ovarian cancer cells that have been treated with the drug MCB-613. Read more.